JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells
- PMID: 12100758
JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells
Abstract
Aim: To investigate whether JTE-522 [4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide], a selective COX-2 inhibitor, can induce apoptosis and inhibit cell proliferation in human endometrial cancer cell line RL95-2 cells and to explore the molecular mechanisms.
Methods: [3-(4,5)-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT), DNA ladder, enzyme-linked immunosorbent assay (ELISA), flow cytometry, RT-PCR, and Western blot analysis were employed to investigate effect of JTE-522 on human endometrial cancer cell line RL95-2 cells and the related molecular mechanisms.
Results: JTE-522 inhibited the growth of RL95-2 cells and induced the apoptosis. Furthermore, it arrested G0/G1 phase and inhibited S phase in RL95-2 cells. JTE-522 inhibited the expressions of COX-2 mRNA, phosphorylated Rb, and CDK4 proteins, while increased the levels of p53, p21, cyclin D1 proteins, and the activity of caspase-3 in RL95-2 cells.
Conclusion: JTE-522 inhibits cell proliferation and induces apoptosis in RL95-2 cells, which may be associated with the activation of caspase-3-like proteases, down-regulation of the expression of COX-2 mRNA, phosphorylated Rb, and CDK4 proteins, and up-regulation of the expressions of p53, p21, and cyclin D1 proteins.
Similar articles
-
Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.Anticancer Res. 2000 Nov-Dec;20(6B):4279-84. Anticancer Res. 2000. PMID: 11205258
-
The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.Anticancer Res. 2003 Jan-Feb;23(1A):245-9. Anticancer Res. 2003. PMID: 12680220
-
Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.Oncol Rep. 2007 Nov;18(5):1281-90. Oncol Rep. 2007. PMID: 17914586
-
[Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].Zhonghua Yi Xue Za Zhi. 2004 Apr 2;84(7):583-6. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15144595 Chinese.
-
Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.Am J Hematol. 2006 Apr;81(4):242-55. doi: 10.1002/ajh.20542. Am J Hematol. 2006. PMID: 16550520
Cited by
-
Synergistic effects of nimesulide and 5-fluorouracil on tumor growth and apoptosis in the implanted hepatoma in mice.World J Gastroenterol. 2003 May;9(5):936-40. doi: 10.3748/wjg.v9.i5.936. World J Gastroenterol. 2003. PMID: 12717833 Free PMC article.
-
PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells.World J Gastroenterol. 2003 Jun;9(6):1220-6. doi: 10.3748/wjg.v9.i6.1220. World J Gastroenterol. 2003. PMID: 12800228 Free PMC article.
-
PC-407, a celecoxib derivative, inhibited the growth of colorectal tumor in vitro and in vivo.Cancer Sci. 2009 Dec;100(12):2451-8. doi: 10.1111/j.1349-7006.2009.01335.x. Epub 2009 Sep 1. Cancer Sci. 2009. PMID: 19814734 Free PMC article.
-
Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells.Cancer Sci. 2004 Nov;95(11):901-7. doi: 10.1111/j.1349-7006.2004.tb02200.x. Cancer Sci. 2004. PMID: 15546508 Free PMC article.
-
The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer.Cancers (Basel). 2018 Jul 30;10(8):251. doi: 10.3390/cancers10080251. Cancers (Basel). 2018. PMID: 30061485 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
